Pharmacotherapy for Anxiety Disorders
Psychiatric Clinics of North America · 2024-12 · 47 (4) · 689-709
DOI: 10.1016/j.psc.2024.04.012 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Psychiatric Clinics of North America, 2024-12. Verfasst von Kerry B O'Leary und 1 weiteren Autor:innen. Beteiligte Einrichtung: Menninger Department of Psychiatry & Behavioral Sciences, Baylor College of Medicine, 1 Baylor Plaza - BCM350, Houston, TX 77030, USA. Electronic add…. Hauptthemen laut MEDLINE: Anxiety Disorders, Selective Serotonin Reuptake Inhibitors. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 117 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Menninger Department of Psychiatry & Behavioral Sciences, Baylor College of Medicine, 1 Baylor Plaza - BCM350, Houston, TX 77030, USA. Electronic address: Kerry.O'Leary@bcm.edu.
- Menninger Department of Psychiatry & Behavioral Sciences, Baylor College of Medicine, 1977 Butler Boulevard, E4.203. Houston, TX 77030, USA.
Zitieren
APA
O'Leary, K. B., & Khan, J. S. (2024). Pharmacotherapy for Anxiety Disorders. Psychiatric Clinics of North America, 47(4), 689-709. https://doi.org/10.1016/j.psc.2024.04.012
Vancouver
O'Leary KB, Khan JS. Pharmacotherapy for Anxiety Disorders. Psychiatric Clinics of North America. 2024;47(4):689-709. doi:10.1016/j.psc.2024.04.012
BibTeX
@article{OLeary2024,
author = {O'Leary, Kerry B and Khan, Jeffrey S},
title = {Pharmacotherapy for Anxiety Disorders},
journal = {Psychiatric Clinics of North America},
year = {2024},
volume = {47},
number = {4},
pages = {689--709},
doi = {10.1016/j.psc.2024.04.012}
}
EUVIMED